ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728979; 2) Community: the network communities that were significantly associated with the response to NSC 728979; 3) Molecule: the relationships between components within communities and NSC 728979; 4) MDR: the compounds that were significantly associated with the NSC 728979.

NSC Compound Enrichment Correlation
NSC 707904 Null 0.00415749398947839 0.31261675
NSC 714379 Null 0.00415749398947839 0.15381089
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.00415749398947839 0.29058507
NSC 87868 2-Phenylethyl isothiocyanate 0.00415749398947839 0.15660218
NSC 132313 Dianhydrogalactitol 0.0041872854493286 0.57241188
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0041872854493286 0.41598419
NSC 244404 Null 0.0041872854493286 0.19262462
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0041872854493286 0.50210493
NSC 328410 Camptothecin Derivative 0.0041872854493286 0.59514541
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0041872854493286 0.52004691
Total:100  Current:12    [First] [Prev] [Next] [Last]